Zhi-Yao Zhang (Zhiyao Zhang)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 11

Top Topics

Newly Diagnosed

Multiple Myeloma

Ejection Fraction

Top Venues

Journal of personalized medicine

Cancer medicine

Hematological oncology

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Chuanying Geng, Guangzhong Yang, Huixing Zhou, Huijuan Wang, Yanchen Li, Yun Leng, Zhi-Yao Zhang, Yuan Jian, Wenming Chen
Characteristics and Risk Factors of Ultra-High-Risk Patients with Newly Diagnosed Multiple Myeloma. Journal of personalized medicine 13 (4) (2023)
Chuanying Geng, Guangzhong Yang, Huixing Zhou, Huijuan Wang, Yanchen Li, Yun Leng, Zhi-Yao Zhang, Yuan Jian, Wenming Chen
Characteristics and Risk Factors of Ultra-High-Risk Patients with Newly Diagnosed Multiple Myeloma. Journal of personalized medicine 13 (4) (2023)
Chuanying Geng, Guangzhong Yang, Huixing Zhou, Huijuan Wang, Yanchen Li, Yun Leng, Zhi-Yao Zhang, Yuan Jian, Wenming Chen
Characteristics and Risk Factors of Ultra-High-Risk Patients with Newly Diagnosed Multiple Myeloma. Journal of personalized medicine 13 (4) (2023)
Chuanying Geng, Guangzhong Yang, Huixing Zhou, Huijuan Wang, Yanchen Li, Yun Leng, Zhi-Yao Zhang, Yuan Jian, Wenming Chen
Characteristics and Risk Factors of Ultra-High-Risk Patients with Newly Diagnosed Multiple Myeloma. Journal of personalized medicine 13 (4) (2023)
Huixing Zhou, Yuan Jian, Juan Du, Junru Liu, Zhi-Yao Zhang, Guangzhong Yang, Guorong Wang, Ying Tian, Yanchen Li, Yin Wu, Wenming Chen, Weijun Fu, Juan Li, Wen Gao
Prognostic nomogram for multiple myeloma early relapse after autologous stem cell transplant in the novel agent era. Cancer medicine (2023)
Yuan Jian, Huixing Zhou, Yidan Wang, Zhi-Yao Zhang, Guangzhong Yang, Chuanying Geng, Ying Tian, Wen Gao, Wenming Chen
Echocardiography-defined pulmonary hypertension is an adverse prognostic factor for newly diagnosed multiple myeloma patients. Cancer medicine 11 (22) (2022)
Yun Leng, Xiaoyan Hu, Lin Li, Jewel Nkwocha, Toshihisa Satta, Kanika Sharma, Maciej Kmeiciak, Huixing Zhou, Zhi-Yao Zhang, Liang Zhou, Wenming Chen, Steven Grant
Mechanisms underlying synergism between circularized tumor necrosis factor-related apoptosis inducing ligand and bortezomib in bortezomib-sensitive or -resistant myeloma cells. Hematological oncology (2022)
Chuanying Geng, Guangzhong Yang, Huijuan Wang, Yin Wu, Yun Leng, Huixing Zhou, Zhi-Yao Zhang, Yuan Jian, Wenming Chen
Deep and partial immunoparesis is a poor prognostic factor for newly diagnosed multiple myeloma patients. Leukemia & lymphoma 62 (4) (2020)
Wen Gao, Yuan Jian, Juan Du, Xiaozhe Li, Huixing Zhou, Zhi-Yao Zhang, Guangzhong Yang, Guorong Wang, Ying Tian, Yanchen Li, Yin Wu, Weijun Fu, Juan Li, Wenming Chen
Gain of 1q21 is an adverse prognostic factor for multiple myeloma patients treated by autologous stem cell transplantation: A multicenter study in China. Cancer medicine 9 (21) (2020)
Zhi-Yao Zhang, Yan-Chen Li, Chuan-Ying Geng, Hui-Xing Zhou, Wen Gao, Wen-Ming Chen
Serum exosomal microRNAs as novel biomarkers for multiple myeloma. Hematological oncology 37 (4) (2019)
Zhi-Yao Zhang, Yan-Chen Li, Chuan-Ying Geng, Hui-Juan Wang, Wen-Ming Chen
Potential Relationship between Clinical Significance and Serum Exosomal miRNAs in Patients with Multiple Myeloma. BioMed research international 2019 (2019)